The Company reports Record Full Year Net
Revenue, Gross Profit and Gross Margin, as well as positive Cash
Flow and Free Cash Flow
CALGARY,
AB, March 18, 2025 /PRNewswire/ - SNDL
Inc. (NASDAQ: SNDL) ("SNDL" or the "Company")
reported its financial and operational results for the full year
and fourth quarter ended December 31,
2024. All financial information in this press release is
reported in millions of Canadian dollars unless otherwise
indicated.
SNDL has also posted a supplemental investor presentation and
shareholder letter on its website, found at https://sndl.com.
The Company will hold a conference call and webcast
presentation at 10:00 a.m. EDT
(8:00 a.m. MDT) on Tuesday, March 18, 2025. The conference call
details can be found below.
MANAGEMENT HIGHLIGHTS
- Net revenue for the fourth quarter of 2024 was $257.7 million, and $920.4
million for the full year of 2024, representing growth of
+3.7% and +1.3%, respectively, when compared to the same periods of
the previous year. Both the quarter and the full year represent new
records for the corporation, driven by strong growth from our
combined Cannabis business of +16.5% in the fourth quarter and
+10.6% over the full year.
- Gross profit also reached new records, with $68.8 million in the fourth quarter of 2024, and
$240.3 million for the full year,
representing growth of +20.0% and +26.2%, respectively, when
compared to the same periods of the previous year.
- Gross margin (1) of 26.7% in the fourth quarter of
2024 and 26.1% for the full year are also new records, representing
improvements of +3.6 and +5.2 percentage points, respectively, when
compared to the same periods of the previous year.
- Operating loss was $(76.1)
million for the fourth quarter of 2024, driven by a negative
valuation adjustment of the SunStream portfolio of $(65.7) million, a Spiritleaf intangible
write-off of $(15.0) million, and
restructuring charges of $(0.6)
million. Excluding these exceptional items adding up to
$(81.3) million, our underlying
Operating Income would have been positive for the quarter. These
exceptional items largely contributed to the full year reported
Operating loss of $(103.8)
million.
- Cash flow was negative by $(44.6)
million in the fourth quarter of 2024, driven by the
acquisition of Nova's minority equity interest, as well as the
repurchase of SNDL's common shares. Full-year cash flow was
positive by $23.3 million.
- Free cash flow (1) was positive both in the fourth
quarter of 2024, at $11.6 million,
and for the full year, at $8.9
million.
"We are pleased with the continued progress reflected in our
fourth-quarter and full-year 2024 results, as we set new records
and exceeded our commitment to achieving break-even free cash flow
for the year. We have accomplished this while continuing to
transform our business by investing in growth opportunities and
strengthening our organizational capabilities. The SNDL team
remains dedicated to raising the bar in 2025 and beyond," said
Zach George, Chief Executive Officer
of SNDL.
"During the fourth quarter of 2024 and the first months of 2025
up to this date, we took several strategic steps to enhance our
foundation for long-term success and shareholder value:
- Completed the privatization of Nova Cannabis Inc. through the
acquisition of the remaining minority equity interest
- Acquired business and assets of Indiva Inc. ("Indiva"),
positioning SNDL as the largest manufacturer of infused edibles in
Canada
- Received approval from the Florida Department of Health for the
transfer of the Parallel (Surterra Holdings, Inc.) license - an
important milestone and prerequisite for completing the Parallel
restructuring process
- Repurchased 10,764,107 SNDL common shares for cancellation at
an average price of US$1.81 per
share
- Acquired 4,350,000 common shares of High Tide Inc. ("High
Tide"), equivalent to 5.4% ownership
In addition to these achievements, the Company has applied for
listing of its common shares on the Canadian Securities Exchange
("CSE") and anticipate the CSE listing to go live in April 2025, providing our shareholders with
increased flexibility and optionality.
The progress made during the last year in operational
performance and financial discipline is undeniable, and we are
encouraged by the many opportunities we still have ahead of us. Our
strong balance sheet, including $218.4
million of unrestricted cash as of December 31, 2024, is not only a competitive
differentiator but also gives us the flexibility to thoughtfully
deploy capital into organic and inorganic investments with
attractive returns. Our plan is to continue building strong
fundamentals, as we expect to build momentum through 2025 with the
goal of generating $100 million in
positive annual free cash flow within the next three years.
We want to thank our employees for their dedication and passion
in delivering the progress we made during the last year, as well as
our shareholders for their continued trust and support," concluded
Zach George.
TOTAL COMPANY HIGHLIGHTS
|
Three months ended
December 31
|
|
Year ended
December 31
|
|
($000s)
|
2024
|
|
2023
|
|
%
Change
|
|
2024
|
|
2023
|
|
%
Change
|
|
IFRS Financial
Measures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue
|
|
257,679
|
|
|
248,450
|
|
|
3.7
|
%
|
|
920,448
|
|
|
909,006
|
|
|
1.3
|
%
|
Gross profit
|
|
68,799
|
|
|
57,336
|
|
|
20.0
|
%
|
|
240,331
|
|
|
190,415
|
|
|
26.2
|
%
|
Operating
loss
|
|
(76,089)
|
|
|
(85,017)
|
|
|
10.5
|
%
|
|
(103,811)
|
|
|
(163,171)
|
|
|
36.4
|
%
|
Change in cash and cash
equivalents
|
|
(44,617)
|
|
|
(6,942)
|
|
|
-543
|
%
|
|
23,318
|
|
|
(84,545)
|
|
|
128
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-IFRS Financial
Measures (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
26.7
|
%
|
|
23.1
|
%
|
|
3.6
|
pp
|
|
26.1
|
%
|
|
20.9
|
%
|
|
5.2
|
pp
|
Adjusted operating
loss
|
|
(60,472)
|
|
|
(27,094)
|
|
|
-123
|
%
|
|
(86,144)
|
|
|
(98,028)
|
|
|
12
|
%
|
Free cash
flow
|
|
11,625
|
|
|
1,383
|
|
|
741
|
%
|
|
8,872
|
|
|
(60,883)
|
|
|
115
|
%
|
(1)
|
Gross Margin is a
supplementary financial measure calculated by dividing Gross Profit
by Net Revenue. Adjusted operating income (loss) and Free Cash Flow
are specified financial measures that do not have a standardized
meanings prescribed by IFRS and therefore may not be comparable to
similar measures reported by other companies. See "Non-IFRS
Measures" section below for further information.
|
BUSINESS SEGMENT HIGHLIGHTS
SNDL's business is operated and reported in four segments:
Liquor Retail, Cannabis Retail, Cannabis Operations and
Investments. Corporate and Shared Service expenses, as well as the
revenue elimination associated with the Cannabis Operations sales
to the provincial boards that are expected to be subsequently
repurchased by the Company's licensed retail subsidiaries for
resale, are reported as "Corporate".
|
Three months ended
December 31
|
|
Year ended
December 31
|
|
($000s)
|
2024
|
|
2023
|
|
%
Change
|
|
2024
|
|
2023
|
|
%
Change
|
|
Net
Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquor
Retail
|
|
154,080
|
|
|
159,493
|
|
|
-3.4
|
%
|
|
555,259
|
|
|
578,895
|
|
|
-4.1
|
%
|
Cannabis
Retail
|
|
83,170
|
|
|
75,152
|
|
|
10.7
|
%
|
|
311,689
|
|
|
289,980
|
|
|
7.5
|
%
|
Cannabis
Operations
|
|
37,092
|
|
|
26,044
|
|
|
42.4
|
%
|
|
109,470
|
|
|
87,071
|
|
|
25.7
|
%
|
Investments
|
|
—
|
|
|
—
|
|
|
0
|
%
|
|
—
|
|
|
—
|
|
|
0
|
%
|
Corporate
|
|
(16,663)
|
|
|
(12,239)
|
|
|
-36.1
|
%
|
|
(55,970)
|
|
|
(46,940)
|
|
|
-19.2
|
%
|
Total
|
|
257,679
|
|
|
248,450
|
|
|
3.7
|
%
|
|
920,448
|
|
|
909,006
|
|
|
1.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquor
Retail
|
|
12,325
|
|
|
10,120
|
|
|
21.8
|
%
|
|
34,781
|
|
|
24,655
|
|
|
41.1
|
%
|
Cannabis
Retail
|
|
(8,997)
|
|
|
(849)
|
|
|
-959.7
|
%
|
|
(1,742)
|
|
|
4,840
|
|
|
-136.0
|
%
|
Cannabis
Operations
|
|
4,391
|
|
|
(65,749)
|
|
|
106.7
|
%
|
|
2,663
|
|
|
(112,744)
|
|
|
102.4
|
%
|
Investments
|
|
(63,724)
|
|
|
(5,217)
|
|
|
-1121.5
|
%
|
|
(50,013)
|
|
|
11,746
|
|
|
-525.8
|
%
|
Corporate
|
|
(20,084)
|
|
|
(23,322)
|
|
|
13.9
|
%
|
|
(89,500)
|
|
|
(91,668)
|
|
|
2.4
|
%
|
Total
|
|
(76,089)
|
|
|
(85,017)
|
|
|
-10.5
|
%
|
|
(103,811)
|
|
|
(163,171)
|
|
|
400.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Operating
Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquor
Retail
|
|
12,325
|
|
|
10,120
|
|
|
21.8
|
%
|
|
34,781
|
|
|
24,655
|
|
|
41.1
|
%
|
Cannabis
Retail
|
|
6,003
|
|
|
(849)
|
|
|
807.1
|
%
|
|
13,258
|
|
|
4,840
|
|
|
173.9
|
%
|
Cannabis
Operations
|
|
4,439
|
|
|
(7,715)
|
|
|
157.5
|
%
|
|
3,091
|
|
|
(52,728)
|
|
|
105.9
|
%
|
Investments
|
|
(63,724)
|
|
|
(5,217)
|
|
|
-1121.5
|
%
|
|
(50,013)
|
|
|
11,746
|
|
|
-525.8
|
%
|
Corporate
|
|
(19,515)
|
|
|
(23,433)
|
|
|
16.7
|
%
|
|
(87,261)
|
|
|
(86,541)
|
|
|
-0.8
|
%
|
Total
|
|
(60,472)
|
|
|
(27,094)
|
|
|
-1355.1
|
%
|
|
(86,144)
|
|
|
(98,028)
|
|
|
133.4
|
%
|
Liquor Retail
SNDL is Canada's largest
private sector liquor retailer, operating at March 17, 2025 in 165 locations, predominantly
in Alberta, under its three retail banners: "Wine and
Beyond" (13), "Liquor Depot" (19), and "Ace
Liquor" (133).
|
Three months ended
December 31
|
|
Year ended
December 31
|
|
($000s)
|
2024
|
|
2023
|
|
%
Change
|
|
2024
|
|
2023
|
|
%
Change
|
|
Net Revenue
|
|
154,080
|
|
|
159,493
|
|
|
-3.4
|
%
|
|
555,259
|
|
|
578,895
|
|
|
-4.1
|
%
|
Gross Profit
|
|
38,236
|
|
|
38,396
|
|
|
-0.4
|
%
|
|
139,706
|
|
|
137,286
|
|
|
1.8
|
%
|
Gross margin
|
|
24.8
|
%
|
|
24.1
|
%
|
|
0.7
|
pp
|
|
25.2
|
%
|
|
23.7
|
%
|
|
1.4
|
pp
|
Operating
Income
|
|
12,325
|
|
|
10,120
|
|
|
21.8
|
%
|
|
34,781
|
|
|
24,655
|
|
|
41.1
|
%
|
Adjusted Operating
Income
|
|
12,325
|
|
|
10,120
|
|
|
21.8
|
%
|
|
34,781
|
|
|
24,655
|
|
|
41.1
|
%
|
- Net revenue for Liquor Retail continued to decline in the
fourth quarter of 2024, although at a slightly slower pace than in
previous quarters, as we continue to experience market demand
softness. Same store sales (2) decreased by -3.5%
in the fourth quarter, and -4.6% for the full year.
- Operating Income expanded significantly in both the fourth
quarter and the full year, despite the revenue declines, driven by
the introduction early in the year of our proprietary data
licensing program, enhanced pricing and mix management strategies,
including private label expansion at accretive margins, as well as
cost optimization and in-store productivity improvements.
(2)
|
Same store sales are
specified financial measures that do not have standardized meanings
prescribed by IFRS Accounting Standards and therefore may not be
comparable to similar measures used by other companies. Refer to
the "Non-IFRS Financial Measures and Other Measures" section of
this MD&A for further information.
|
Cannabis Retail
SNDL is one of Canada's largest
private-sector cannabis retailer, operating at March 17, 2025 in 185 locations under its three
retail banners: "Value Buds" (117), "Spiritleaf" (67,
of which 8 are corporate stores and 59 are franchise stores), and
"Superette" (1). The Company's Cannabis Retail strategy is
based on several pillars, including the quality of its store
locations, its range of products, and the unique experiences
provided to customers. Using data and insights from a large volume
of monthly transactions enables SNDL to leverage technology and
analytics to inform and improve its retail strategy.
|
Three months ended
December 31
|
|
Year ended
December 31
|
|
($000s)
|
2024
|
|
2023
|
|
%
Change
|
|
2024
|
|
2023
|
|
%
Change
|
|
Net Revenue
|
|
83,170
|
|
|
75,152
|
|
|
10.7
|
%
|
|
311,689
|
|
|
289,980
|
|
|
7.5
|
%
|
Gross Profit
|
|
20,490
|
|
|
20,045
|
|
|
2.2
|
%
|
|
78,827
|
|
|
73,690
|
|
|
7.0
|
%
|
Gross margin
|
|
24.6
|
%
|
|
26.7
|
%
|
|
-2.0
|
pp
|
|
25.3
|
%
|
|
25.4
|
%
|
|
-0.1
|
pp
|
Operating
Income
|
|
(8,997)
|
|
|
(849)
|
|
|
-959.7
|
%
|
|
(1,742)
|
|
|
4,840
|
|
|
-136.0
|
%
|
Adjusted Operating
Income
|
|
6,003
|
|
|
(849)
|
|
|
807.1
|
%
|
|
13,258
|
|
|
4,840
|
|
|
173.9
|
%
|
- Net revenue for Cannabis Retail grew dynamically over the full
year, and particularly in the fourth quarter, as our Value Buds
banner continues to gain market share, and we also run some
additional promotional activities in the fourth quarter. Same store
sales increased by +6.3% in the fourth quarter, and +3.5% over the
full year.
- Operating Income was impacted in the fourth quarter by a
$15 million Spiritleaf
intangible asset impairment, as we have converted several
Spiritleaf stores into Value Buds. These conversions are increasing
revenue, profitability and cash flow, and therefore create
shareholder value. However, when the profit pool associated with
the Spiritleaf intangible asset was reduced, it triggered the
one-time non-cash impairment.
- Adjusted Operating Income excludes the Spiritleaf
intangible impairment, showing the underlying operational
profitability of the segment, which has seen a material improvement
when compared to the previous year, both in the fourth quarter and
the full year.
Cannabis Operations
SNDL has a diverse brand portfolio from value to premium,
emphasizing premium inhalable formats and a full suite of 2.0
products. With enhanced procurement capabilities and plans to
continue evolving toward a cost-effective cultivation and
manufacturing operation, the Cannabis Operations segment is a key
enabler of SNDL's vertical integration strategy.
|
Three months ended
December 31
|
|
Year ended
December 31
|
|
($000s)
|
2024
|
|
2023
|
|
%
Change
|
|
2024
|
|
2023
|
|
%
Change
|
|
Net Revenue
|
|
37,092
|
|
|
26,044
|
|
|
42.4
|
%
|
|
109,470
|
|
|
87,071
|
|
|
25.7
|
%
|
Gross Profit
|
|
10,073
|
|
|
(1,105)
|
|
|
1011.6
|
%
|
|
21,798
|
|
|
(20,561)
|
|
|
206.0
|
%
|
Gross margin
|
|
27.2
|
%
|
|
-4.2
|
%
|
|
31.4
|
pp
|
|
19.9
|
%
|
|
-23.6
|
%
|
|
43.5
|
pp
|
Operating
Income
|
|
4,391
|
|
|
(65,749)
|
|
|
106.7
|
%
|
|
2,663
|
|
|
(112,744)
|
|
|
102.4
|
%
|
Adjusted Operating
Income
|
|
4,439
|
|
|
(7,715)
|
|
|
157.5
|
%
|
|
3,091
|
|
|
(52,728)
|
|
|
105.9
|
%
|
- Cannabis Operations reported a significant step up in revenues
and profitability throughout the year, and particularly in the
fourth quarter of 2024.
- Net revenue expansion is driven by increased provincial board
and Business-to-Business distribution and a continued focus on
consumer innovation, quality and operational efficiencies. Reported
revenue includes $7.5 million from
Indiva between November 4 and December 31,
2024.
- Gross profit and Operating Income improvements are driven by
efficiency improvements from scale as well as productivity
initiatives.
Investments
- As of December 31, 2024, the
Company has deployed capital to a portfolio of cannabis-related
investments with a carrying value of $449.1
million, including $413.1
million to SunStream Bancorp Inc. ("SunStream"). This
carrying value was reduced by $51.3
million during the fourth quarter of 2024, mainly driven by
a negative valuation adjustment of the SunStream portfolio.
- In the fourth quarter of 2024, the investment portfolio
generated negative operating income of $(63.7) million, including a $(65.7) million negative valuation adjustment of
equity-accounted investees (SunStream portfolio). This non-cash
valuation adjustment is the consequence of multiple factors,
including increased U.S. industry risk and volatility following the
negative adult use Florida vote
last November, as well as the worsening performance of Parallel and
Skymint investments due to delays in the completion of their
restructuring process while operating in challenging competitive
environments.
- The negative Florida election
vote to legalize adult use cannabis in this state is seen as an
unfavorable development by the industry and the investor community,
as evidenced by the significant declines in equity valuation of
different Cannabis multi-state-operators. For SNDL's investment in
SunStream assets, we find a positive in this development, as it
gives Parallel more time to complete its restructuring process
without the additional competitive pressure of a changing market
environment.
- Subsequent to the end of the fourth quarter, on February 4, 2025, the Florida Department of
Health approved the transfer of Parallel's license. While a few
additional steps are still required, this is an important milestone
in completing Parallel's restructuring process.
- On March 17, 2025 the Company
announced the purchase of 4,350,000 common shares of High Tide,
equivalent to 5.4% ownership, at an average price of US$2.46 per share.
Equity Position
- $667.6 million of unrestricted
cash, marketable securities and investments, including investments
in equity-accounted investees, and no outstanding debt at
December 31, 2024, resulting in a net
book value of $1.1 billion.
- On November 14, 2024, the Company
announced that its board of directors had approved a renewal of the
share repurchase program upon its expiry on November 20, 2024. The Company's share repurchase
program continues to be available to lower the outstanding share
float. SNDL will continue to assess opportunities to utilize the
program to the extent that management believes it is in the best
interest of SNDL's shareholders. During the three months ending
December 31, 2024, the Company
repurchased 5,002,372 common shares for cancelation at an average
price of US$1.84 per share.
Subsequent to the quarter end, in January and February 2025 the Company repurchased an
additional 5,761,735 common shares for cancellation at an average
price of US$1.79 per share. This
brings the total number of common shares repurchased during the
last 6 months to a total of 10,764,107 at an average price of
US$1.81 per share.
This press release is intended to be read in conjunction with
the Company's consolidated financial statements and the notes
thereto for the years ended December 31,
2024 and 2023, and the accompanying Management's Discussion
and Analysis. These documents are available under the Company's
profile on SEDAR+ at www.sedarplus.ca and EDGAR at
www.sec.gov/edgar.shtml.
CONFERENCE CALL
The Company will hold a conference call and webcast
presentation at 10:00 a.m. EDT
(8:00 a.m. MDT) on Tuesday, March 18, 2025.
WEBCAST ACCESS
To access the live webcast of the call,
please visit the following link:
https://edge.media-server.com/mmc/p/yxxmbsby
REPLAY
A replay of the webcast will be available at
https://sndl.com/financials/quarterly-results/default.aspx
ABOUT SNDL INC.
SNDL Inc. (NASDAQ: SNDL), through its wholly owned subsidiaries,
is one of the largest vertically integrated cannabis companies and
the largest private-sector liquor and cannabis retailer
in Canada, with retail banners that include Ace Liquor,
Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf and
Superette. With products available in licensed cannabis retail
locations nationally, SNDL's consumer-facing cannabis brands
include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus,
Value Buds, Grasslands, Vacay, Pearls by Grön, No Future and Bhang
Chocolate. SNDL's investment portfolio seeks to deploy strategic
capital through direct and indirect investments and partnerships
throughout the North American cannabis industry. For more
information, please visit www.sndl.com
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"), including, but not
limited to, statements regarding the Company's operational goals
and plans, the anticipated impact of the Company's strategic steps
on long-term success and shareholder value, the Company's
intentions to activate a listing on the CSE and anticipated timing
thereof, the anticipated benefit of the Company's strong balance
sheet, the Company's strategy with respect to its operating
segments, the impact of the negative Florida election vote to legalize adult use
cannabis, expectations with respect to the Parallel restructuring
process, the Company's margin improvement initiatives, the
Company's ability to achieve long-term, sustainable profitability,
growth and efficiencies, the Company's long-term strategic plan,
the benefits of the Company's Investment Segment portfolio,
expectations with respect to sharing information with investors,
the Company's retail strategy, expectations with respect to the
Company's Cannabis Operations segment, the Company's vertical
integration strategy, the Company's proprietary data licensing
program, expansion of product offerings (including the expected
expansion of the Company's private labels), performance of the
Company's investments, including through the SunStream joint
venture and SunStream USA Group,
expectations with respect to the SunStream USA Group, the timing and closing of the
transactions with Parallel and Skymint, potential local and
international regulatory changes, the share repurchase program,
including the anticipated benefits thereof, and any other potential
forms of shareholder value creation. Forward-looking statements are
frequently characterized by words such as "aim", "anticipate",
"assume", "believe", "contemplate", "continue", "could", "due",
"estimate", "expect", "goal", "intend", "may", "objective", "plan",
"predict", "potential", "positioned", "pioneer", "seek", "should",
"target", "will", "would", and other similar expressions that are
predictions of or indicate future events and future trends, or the
negative of these terms or other comparable terminology. These
forward-looking statements are based on current expectations,
estimates, forecasts and projections about the Company's business
and the industry in which it operates and management's beliefs and
assumptions and are not guarantees of future performance or
development and involve known and unknown risks, uncertainties and
other factors that are in some cases beyond its
control. Forward-looking statements are based on the opinions
and estimates of management at the date the statements are made
and are subject to a variety of risks and uncertainties and other
factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
Please see "Risk Factors" in the Company's Annual Information Form
dated March 18, 2025, and the risk
factors included in our other public disclosure documents for a
discussion of the material risk factors that could cause actual
results to differ materially from the forward-looking information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable
law.
Condensed Consolidated Statement of Loss and
Comprehensive Loss
(Expressed in thousands of Canadian
dollars, except per share amounts)
|
|
Year
ended
December 31
|
|
|
|
2024
|
|
|
2023
|
|
Net
revenue
|
|
|
920,448
|
|
|
|
909,006
|
|
Cost of
sales
|
|
|
680,117
|
|
|
|
718,591
|
|
Gross
profit
|
|
|
240,331
|
|
|
|
190,415
|
|
|
|
|
|
|
|
|
|
|
Investment
income
|
|
|
15,551
|
|
|
|
5,259
|
|
Share of (loss) profit
of equity-accounted investees
|
|
|
(65,459)
|
|
|
|
6,758
|
|
|
|
|
|
|
|
|
|
|
General and
administrative
|
|
|
187,243
|
|
|
|
199,725
|
|
Sales and
marketing
|
|
|
12,004
|
|
|
|
15,045
|
|
Research and
development
|
|
|
346
|
|
|
|
324
|
|
Depreciation and
amortization
|
|
|
54,250
|
|
|
|
60,216
|
|
Share-based
compensation
|
|
|
20,037
|
|
|
|
15,400
|
|
Restructuring
costs
|
|
|
2,667
|
|
|
|
19,573
|
|
Asset impairment,
net
|
|
|
17,317
|
|
|
|
54,967
|
|
Loss on disposition of
assets
|
|
|
370
|
|
|
|
353
|
|
Operating
loss
|
|
|
(103,811)
|
|
|
|
(163,171)
|
|
|
|
|
|
|
|
|
|
|
Other expenses,
net
|
|
|
(1,798)
|
|
|
|
(8,845)
|
|
Loss before income
tax
|
|
|
(105,609)
|
|
|
|
(172,016)
|
|
Income tax
recovery
|
|
|
9,405
|
|
|
|
—
|
|
Net loss from
continuing operations
|
|
|
(96,204)
|
|
|
|
(172,016)
|
|
Net loss from
discontinued operations
|
|
|
—
|
|
|
|
(4,535)
|
|
Net
loss
|
|
|
(96,204)
|
|
|
|
(176,551)
|
|
|
|
|
|
|
|
|
|
|
Equity-accounted
investees - share of other comprehensive income (loss)
|
|
|
31,489
|
|
|
|
(12,771)
|
|
Investments at FVOCI -
change in fair value
|
|
|
1,864
|
|
|
|
—
|
|
Comprehensive
loss
|
|
|
(62,851)
|
|
|
|
(189,322)
|
|
|
|
|
|
|
|
|
|
|
Net loss from
continuing operations attributable to:
|
|
|
|
|
|
|
|
|
Owners of the
Company
|
|
|
(94,796)
|
|
|
|
(168,125)
|
|
Non-controlling
interest
|
|
|
(1,408)
|
|
|
|
(3,891)
|
|
|
|
|
(96,204)
|
|
|
|
(172,016)
|
|
Net loss
attributable to:
|
|
|
|
|
|
|
|
|
Owners of the
Company
|
|
|
(94,796)
|
|
|
|
(172,660)
|
|
Non-controlling
interest
|
|
|
(1,408)
|
|
|
|
(3,891)
|
|
|
|
|
(96,204)
|
|
|
|
(176,551)
|
|
Comprehensive loss
attributable to:
|
|
|
|
|
|
|
|
|
Owners of the
Company
|
|
|
(61,443)
|
|
|
|
(185,431)
|
|
Non-controlling
interest
|
|
|
(1,408)
|
|
|
|
(3,891)
|
|
Condensed Consolidated Statement of
Financial Position
(Expressed in thousands of Canadian
dollars)
As at
|
December 31,
2024
|
|
December 31,
2023
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
218,359
|
|
|
195,041
|
|
Restricted
cash
|
|
19,815
|
|
|
19,891
|
|
Marketable
securities
|
|
139
|
|
|
225
|
|
Accounts
receivable
|
|
28,118
|
|
|
27,059
|
|
Biological
assets
|
|
1,187
|
|
|
429
|
|
Inventory
|
|
127,919
|
|
|
129,060
|
|
Prepaid expenses and
deposits
|
|
16,860
|
|
|
22,464
|
|
Investments
|
|
27,560
|
|
|
3,400
|
|
Assets held for
sale
|
|
19,051
|
|
|
6,375
|
|
Net investment in
subleases
|
|
2,832
|
|
|
2,970
|
|
|
|
461,840
|
|
|
406,914
|
|
Non-current
assets
|
|
|
|
|
|
|
Long-term deposits and
receivables
|
|
3,679
|
|
|
4,837
|
|
Right of use
assets
|
|
115,435
|
|
|
129,679
|
|
Property, plant and
equipment
|
|
145,810
|
|
|
152,916
|
|
Net investment in
subleases
|
|
15,354
|
|
|
18,396
|
|
Intangible
assets
|
|
61,325
|
|
|
73,149
|
|
Investments
|
|
8,427
|
|
|
29,660
|
|
Equity-accounted
investees
|
|
413,124
|
|
|
538,331
|
|
Goodwill
|
|
124,248
|
|
|
119,282
|
|
Total
assets
|
|
1,349,242
|
|
|
1,473,164
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
|
Accounts payable and
accrued liabilities
|
|
56,275
|
|
|
68,210
|
|
Lease
liabilities
|
|
34,256
|
|
|
30,537
|
|
Derivative
warrants
|
|
26
|
|
|
4,400
|
|
|
|
90,557
|
|
|
103,147
|
|
Non-current
liabilities
|
|
|
|
|
|
|
Lease
liabilities
|
|
118,017
|
|
|
136,492
|
|
Other
liabilities
|
|
7,312
|
|
|
4,185
|
|
Total
liabilities
|
|
215,886
|
|
|
243,824
|
|
|
|
|
|
|
|
|
Shareholders'
equity
|
|
|
|
|
|
|
Share
capital
|
|
2,346,728
|
|
|
2,375,950
|
|
Warrants
|
|
667
|
|
|
2,260
|
|
Contributed
surplus
|
|
57,156
|
|
|
73,014
|
|
Contingent
consideration
|
|
—
|
|
|
2,279
|
|
Accumulated
deficit
|
|
(1,323,965)
|
|
|
(1,260,851)
|
|
Accumulated other
comprehensive income
|
|
52,770
|
|
|
19,417
|
|
Total shareholders'
equity
|
|
1,133,356
|
|
|
1,212,069
|
|
Non-controlling
interest
|
|
—
|
|
|
17,271
|
|
Total liabilities
and shareholders' equity
|
|
1,349,242
|
|
|
1,473,164
|
|
Condensed Consolidated Statement of Cash
Flows
(Expressed in thousands of Canadian dollars)
|
|
Year
ended
December 31
|
|
|
|
2024
|
|
|
2023
|
|
Cash provided by
(used in):
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
|
|
|
|
|
|
|
Net loss for the
period
|
|
|
(96,204)
|
|
|
|
(176,551)
|
|
Adjustments
for:
|
|
|
|
|
|
|
|
|
Income tax
recovery
|
|
|
(9,405)
|
|
|
|
—
|
|
Interest and fee
income
|
|
|
(15,637)
|
|
|
|
(14,517)
|
|
Change in fair value
of biological assets
|
|
|
(892)
|
|
|
|
7,936
|
|
Share-based
compensation
|
|
|
20,037
|
|
|
|
15,400
|
|
Depreciation and
amortization
|
|
|
56,711
|
|
|
|
64,946
|
|
Loss on disposition of
assets
|
|
|
370
|
|
|
|
353
|
|
Inventory impairment
and obsolescence
|
|
|
3,707
|
|
|
|
30,644
|
|
Finance costs,
net
|
|
|
7,161
|
|
|
|
11,362
|
|
Change in estimate of
fair value of derivative warrants
|
|
|
(4,374)
|
|
|
|
(6,602)
|
|
Unrealized foreign
exchange loss
|
|
|
108
|
|
|
|
(13)
|
|
Transaction
costs
|
|
|
164
|
|
|
|
1,221
|
|
Bargain purchase
gain
|
|
|
(5,456)
|
|
|
|
—
|
|
Asset impairment,
net
|
|
|
17,317
|
|
|
|
54,967
|
|
Share of loss (profit)
of equity-accounted investees
|
|
|
65,459
|
|
|
|
(6,758)
|
|
Realized loss on
settlement of marketable securities
|
|
|
—
|
|
|
|
138,874
|
|
Unrealized loss (gain)
on marketable securities
|
|
|
86
|
|
|
|
(129,616)
|
|
Proceeds from
settlement of marketable securities
|
|
|
—
|
|
|
|
6,704
|
|
Income distributions
from equity-accounted investees
|
|
|
10,715
|
|
|
|
—
|
|
Interest
received
|
|
|
12,494
|
|
|
|
13,563
|
|
Change in non-cash
working capital
|
|
|
(7,447)
|
|
|
|
(32,875)
|
|
Net cash provided by
(used in) operating activities from continuing
operations
|
|
|
54,914
|
|
|
|
(20,962)
|
|
Net cash provided by
operating activities from discontinued operations
|
|
|
—
|
|
|
|
4,314
|
|
Net cash provided by
(used in) operating activities
|
|
|
54,914
|
|
|
|
(16,648)
|
|
Investing
activities
|
|
|
|
|
|
|
|
|
Additions to property,
plant and equipment
|
|
|
(8,615)
|
|
|
|
(7,845)
|
|
Additions to
intangible assets
|
|
|
(2,404)
|
|
|
|
(87)
|
|
Changes to
investments
|
|
|
(22,617)
|
|
|
|
(732)
|
|
Capital refunds
(contributions) to equity-accounted investees
|
|
|
168
|
|
|
|
(25,089)
|
|
Capital distributions
from equity-accounted investees
|
|
|
89,758
|
|
|
|
—
|
|
Proceeds from disposal
of property, plant and equipment
|
|
|
734
|
|
|
|
1,213
|
|
Acquisitions, net of
cash acquired
|
|
|
(39,644)
|
|
|
|
3,695
|
|
Change in non-cash
working capital
|
|
|
383
|
|
|
|
4,028
|
|
Net cash provided by
(used in) investing activities
|
|
|
17,763
|
|
|
|
(24,817)
|
|
Financing
activities
|
|
|
|
|
|
|
|
|
Change in restricted
cash
|
|
|
76
|
|
|
|
(553)
|
|
Payments on lease
liabilities, net
|
|
|
(36,952)
|
|
|
|
(41,013)
|
|
Repurchase of common
shares
|
|
|
(13,219)
|
|
|
|
(1,536)
|
|
Proceeds from issuance
of shares, net of costs
|
|
|
(59)
|
|
|
|
—
|
|
Issuance of common
shares by subsidiaries
|
|
|
174
|
|
|
|
—
|
|
Distributions declared
by subsidiaries
|
|
|
—
|
|
|
|
(20)
|
|
Change in non-cash
working capital
|
|
|
621
|
|
|
|
42
|
|
Net cash used in
financing activities
|
|
|
(49,359)
|
|
|
|
(43,080)
|
|
Change in cash and cash
equivalents
|
|
|
23,318
|
|
|
|
(84,545)
|
|
Cash and cash
equivalents, beginning of period
|
|
|
195,041
|
|
|
|
279,586
|
|
Cash and cash
equivalents, end of period
|
|
|
218,359
|
|
|
|
195,041
|
|
NON-IFRS MEASURES
Certain specified financial measures in this news release are
non-IFRS measures. These terms are not defined by IFRS and,
therefore, may not be comparable to similar measures reported by
other companies. These non-IFRS financial measures should not be
considered in isolation or as an alternative for or superior to
measures of performance prepared in accordance with IFRS. These
measures are presented and described in order to provide
shareholders and potential investors with additional measures in
understanding the Company's operating results in the same manner as
the management team.
ADJUSTED OPERATING INCOME (LOSS)
Adjusted operating
income (loss) is a non-IFRS financial measure which the Company
uses to evaluate its operating performance in a similar manner to
its management team. The Company defines adjusted operating income
(loss) as operating income (loss) less restructuring costs
(recovery), goodwill and intangible asset impairments and asset
impairments triggered by restructuring activities.
The following tables reconcile adjusted to un-adjusted operating
income (loss) for the periods noted.
($000s)
|
Liquor
Retail
|
|
Cannabis
Retail
|
|
Cannabis
Operations
|
|
Investments
|
|
Corporate
|
|
Total
|
|
Three months ended
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
(loss)
|
|
12,325
|
|
|
(8,997)
|
|
|
4,391
|
|
|
(63,724)
|
|
|
(20,084)
|
|
|
(76,089)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring
costs
|
|
—
|
|
|
—
|
|
|
48
|
|
|
—
|
|
|
569
|
|
|
617
|
|
Goodwill and
intangible asset impairments
|
|
—
|
|
|
15,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,000
|
|
Adjusted operating
income (loss)
|
|
12,325
|
|
|
6,003
|
|
|
4,439
|
|
|
(63,724)
|
|
|
(19,515)
|
|
|
(60,472)
|
|
($000s)
|
Liquor
Retail
|
|
Cannabis
Retail
|
|
Cannabis
Operations
|
|
Investments
|
|
Corporate
|
|
Total
|
|
Three months ended
December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
(loss)
|
|
10,120
|
|
|
(849)
|
|
|
(65,749)
|
|
|
(5,217)
|
|
|
(23,322)
|
|
|
(85,017)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring costs
(recovery)
|
|
—
|
|
|
—
|
|
|
13,398
|
|
|
—
|
|
|
(111)
|
|
|
13,287
|
|
Goodwill and
intangible asset impairments
|
|
—
|
|
|
—
|
|
|
29,000
|
|
|
—
|
|
|
—
|
|
|
29,000
|
|
Impairments triggered
by restructuring
|
|
—
|
|
|
—
|
|
|
15,636
|
|
|
—
|
|
|
—
|
|
|
15,636
|
|
Adjusted operating
income (loss)
|
|
10,120
|
|
|
(849)
|
|
|
(7,715)
|
|
|
(5,217)
|
|
|
(23,433)
|
|
|
(27,094)
|
|
($000s)
|
Liquor
Retail
|
|
Cannabis
Retail
|
|
Cannabis
Operations
|
|
Investments
|
|
Corporate
|
|
Total
|
|
Year ended
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
(loss)
|
|
34,781
|
|
|
(1,742)
|
|
|
2,663
|
|
|
(50,013)
|
|
|
(89,500)
|
|
|
(103,811)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring
costs
|
|
—
|
|
|
—
|
|
|
428
|
|
|
—
|
|
|
2,239
|
|
|
2,667
|
|
Goodwill and
intangible asset impairments
|
|
—
|
|
|
15,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,000
|
|
Adjusted operating
income (loss)
|
|
34,781
|
|
|
13,258
|
|
|
3,091
|
|
|
(50,013)
|
|
|
(87,261)
|
|
|
(86,144)
|
|
($000s)
|
Liquor
Retail
|
|
Cannabis
Retail
|
|
Cannabis
Operations
|
|
Investments
|
|
Corporate
|
|
Total
|
|
Year ended
December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
(loss)
|
|
24,655
|
|
|
4,840
|
|
|
(112,744)
|
|
|
11,746
|
|
|
(91,668)
|
|
|
(163,171)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring
costs
|
|
—
|
|
|
—
|
|
|
14,446
|
|
|
—
|
|
|
5,127
|
|
|
19,573
|
|
Goodwill and
intangible asset impairments
|
|
—
|
|
|
—
|
|
|
29,934
|
|
|
—
|
|
|
—
|
|
|
29,934
|
|
Impairments triggered
by restructuring
|
|
—
|
|
|
—
|
|
|
15,636
|
|
|
—
|
|
|
—
|
|
|
15,636
|
|
Adjusted operating
income (loss)
|
|
24,655
|
|
|
4,840
|
|
|
(52,728)
|
|
|
11,746
|
|
|
(86,541)
|
|
|
(98,028)
|
|
GROSS MARGIN
Gross margin is a supplementary financial measure calculated by
dividing gross profit by net revenue for the periods noted.
FREE CASH FLOW
Free cash flow is a non-IFRS financial measure which the Company
uses to evaluate its financial performance, providing information
which management believes to be useful in understanding and
evaluating the Company's ability to generate positive cash flows as
it removes cash used for non-operational items. The Company defines
free cash flow as the total change in cash and cash equivalents
less cash used for common share repurchases, dividends (if any),
changes to debt instruments, changes to long-term investments, net
cash used for acquisitions plus cash provided by dispositions (if
any).
The following table reconciles free cash flow to change in cash
and cash equivalents for the periods noted.
|
|
Three months
ended
December 31
|
|
|
Year
ended
December 31
|
|
($000s)
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Change in cash and cash
equivalents
|
|
|
(44,617)
|
|
|
|
(6,942)
|
|
|
|
23,318
|
|
|
|
(84,545)
|
|
Adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of common
shares
|
|
|
13,219
|
|
|
|
—
|
|
|
|
13,219
|
|
|
|
1,536
|
|
Changes to long-term
investments
|
|
|
5,033
|
|
|
|
8,325
|
|
|
|
(67,309)
|
|
|
|
25,821
|
|
Acquisitions, net of
cash acquired
|
|
|
37,990
|
|
|
|
—
|
|
|
|
39,644
|
|
|
|
(3,695)
|
|
Free cash
flow
|
|
|
11,625
|
|
|
|
1,383
|
|
|
|
8,872
|
|
|
|
(60,883)
|
|
SAME STORE SALES
Same store sales is a non-IFRS
financial measure which the Company uses to evaluate its financial
performance in its retail segments. Same store sales provides
information which management believes to be useful to investors,
analysts and others in understanding and evaluating the Company's
sales trends excluding the effect of the opening and closure of
stores.
Same store sales refers to the revenue generated by the
Company's existing retail locations during the current and prior
comparison periods.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sndl-reports-fourth-quarter-and-full-year-2024-financial-and-operational-results-302403826.html
SOURCE SNDL Inc.